SecBot SecBot
144 ·Filed Nov 6, 2026

VRTX

VERTEX PHARMACEUTICALS INC / MA
NEUTRAL
Impact 2/10
Horizondays Processed11d 4h ago SEC0001959173-26-007810
Form 144: notice of proposed sale of securities
Actionable Insight • Neutral

The filing is a routine advance notice of a planned sale by the CEO for personal financial planning. The share count is small relative to total outstanding shares and the CEO's likely total holdings. Monitor the actual Form 4 filing after the sale to confirm execution and remaining stake.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+5
Entry
$547.09
T+0 close · Nov 6, 2026 · via day close
Latest settled
−1.55%
T+5 · $538.60
Vs SPY
−4.15%
α at T+5
Next horizon
T+20
in 20d
  1. T+0 · Nov 6 $547.09entry
  2. T+1 · 8d ago +0.69%α −1.68% · $550.87
  3. T+5 · 4d ago −1.55%α −4.15% · $538.60
  4. T+6 · todayOpen
  5. T+20 · in 20d Pending
  6. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Vertex CEO Reshma Kewalramani filed a Form 144 notice of intent to sell 11,866 shares of common stock, with an approximate market value of $6.3 million based on the filing date. The shares were acquired through ESPP purchases and restricted stock vesting between May 2024 and August 2025. This represents a routine insider sale for diversification or tax planning, not a change in fundamental outlook.

Key Facts

  • CEO Reshma Kewalramani filed Form 144 on 2026-11-06 to sell 11,866 shares of VRTX common stock.
  • Estimated aggregate market value of the proposed sale is $6,307,134.98 based on the filing date price.
  • Shares were acquired through ESPP purchases (69 shares on 05/14/2024, 53 shares on 05/14/2025) and restricted stock vesting (1,744 shares on 02/24/2025, 10,000 shares on 08/06/2025).
  • The sale is planned for execution on or after 11/06/2026 on Nasdaq.
  • The filing is signed by Fidelity Brokerage Services LLC as attorney-in-fact for the CEO.

Financial Impact

Proposed sale of 11,866 shares valued at approximately $6.3 million, representing about 0.0045% of Vertex's $139.2B market cap.

dilution

Risk Factors

  • Form 144 is an intent to sell; the actual sale may not occur or may be at a different price.
  • CEO sales can be misinterpreted by the market as a lack of confidence, though the small size here mitigates that risk.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
82% bullish (39 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001959173-26-007810
Document: 0001959173-26-007810-index.html0001959173-26-007810
Document: 0001959173-26-007810.txt0001959173-26-007810

Track record

21 reports on VRTX

Performance horizon

3 of 4 bullish or bearish reports moved the stock their way by T+5. Best: +10.87% at T+60 after the Feb 25, 2026 report. 4 of 4 went positive at some point.

Filters
  1. Nov 16, 2026today Insider Cluster Neutral 2/10 Entry $537.79 Now $531.45 −1.18% settles Nov 24
  2. Nov 16, 20261d ago 144 Neutral 2/10 Entry $543.10 Now $531.45 −2.15% settles Nov 23
  3. Nov 16, 20261d ago 144 Neutral 1/10 Entry $544.98 Now $531.45 −2.48% settles Nov 23
  4. Nov 13, 20263d ago SC 13G/A Neutral 2/10 Entry $542.00 Now $531.45 −1.95% settles Nov 23
  5. Nov 12, 20265d ago 144 Neutral 2/10 Entry $542.62 Now $531.45 −2.06% settles Nov 19
  6. Nov 6, 202611d ago 144 Neutral 2/10 Viewing Entry $547.09 to $538.60 Now $531.45 −2.86% ▼ −1.55% −4.15% vs SPY
  7. Nov 2, 202614d ago 8-K Bullish 6/10 Entry $530.76 to $547.89 Now $531.45 +0.13% ▲ +3.23% +3.81% vs SPY
  8. Oct 22, 202626d ago 3 Neutral 2/10 Entry $523.93 to $558.88 Now $531.45 +1.44% ▲ +6.67% +7.23% vs SPY
  9. Oct 20, 202628d ago 8-K Neutral 2/10 Entry $524.52 to $521.03 Now $531.45 +1.32% ▼ −0.67% −0.22% vs SPY
  10. Oct 16, 20264w ago Institutional Cluster Bullish 4/10 Entry $500.36 to $517.49 Now $531.45 +6.21% ▲ +3.42% +3.57% vs SPY
Showing 10 of 21

US Market Status

Market Open · Closes in 43m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 6, 2026